Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase-Reference-Cited by-同舟云学术

Molecular and cellular studies evaluating a potent 2-cyanoindolizine catechol diether NNRTI targeting wildtype and Y181C mutant HIV-1 reverse transcriptase

Published:2019-08 Issue:16 Volume:29 Page:2182-2188
ISSN:0960-894X
Container-title:Bioorganic & Medicinal Chemistry Letters
language:en
Short-container-title:Bioorganic & Medicinal Chemistry Letters

Author:

Sasaki Tomoaki,Gannam Zachary T.K.,Kudalkar Shalley N.^ORCID,Frey Kathleen M.,Lee Won-Gil,Spasov Krasimir A.,Jorgensen William L.,Anderson Karen S.

Funder

NIH

NSF

NIH F31 fellowship

National Cancer Institute

U.S. Department of Energy

Office of Science

DOE

Brookhaven National Laboratory

McGill University

Publisher

Elsevier BV

Subject

Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry

Reference34 articles.

1. U.J.P.o.H.A. (UNAIDS), 2012 Report on the Global AIDS Epidemic, 2012.

2. Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets;Adamson;Mol Interventions,2009

3. Novel approaches to inhibiting HIV-1 replication;Adamson;Antiviral Res,2010

4. Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance;Tantillo;J Mol Biol,1994

5. Natural history of HIV infection in the era of combination antiretroviral therapy;Moore;AIDS (London, England),1999

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring novel HIV‐1 reverse transcriptase inhibitors with drug‐resistant mutants: A double mutant surprise;Protein Science;2023-11-20

2. Rational design of allosteric modulators: Challenges and successes;WIREs Computational Molecular Science;2021-06-24

3. Structural Insights to Human Immunodeficiency Virus (HIV-1) Targets and Their Inhibition;Antiviral Drug Discovery and Development;2021